DalsiClear 60mg

20.00% OFF

Availability In Stock

Rs. 6000
Rs. 4800

Composition : Daclatasvir Dihydrochloride 60mg
Marketed by : Abbott India Limited
Manufactured by : Hetero Labs Limited
Packing : Pack of 28 Tablets

Prescription Required. *


Daclatasvir was discovered as a first-in-class inhibitor of the non-structural viral protein 5A (NS5A), a phosphoprotein that plays an important role in hepatitis C replication. The exact mechanism by which daclatasvir inhibits the NS5A replication complex is unclear, but it is believed that daclatasvir inhibits viral RNA replication and virion assembly.


Daclatasvir is an antiviral medicine that prevents hepatitis C virus (HCV) from multiplying in your body. Daclatasvir is used to treat genotype 3 chronic hepatitis C in adults without cirrhosis. This medicine is given together with another drug called sofosbuvir.

Daclatasvir must be given in combination with sofosbuvir and it should not be used alone.


Get emergency medical help if you have signs of an allergic reaction: hives; difficult breathing; swelling of your face, lips, tongue, or throat.

If you take daclatasvir with sofosbuvir and you also take a heart rhythm medicine called amiodarone: This combination of medicines can cause dangerous side effects on your heart. Get medical help right away if you take these medicines and you have:

very slow heartbeats; chest pain, shortness of breath; or a light-headed feeling, like you might pass out.
Call your doctor at once if you have serious side effects of daclatasvir, including:

confusion, memory problems; severe dizziness; weakness, tiredness; or general ill feeling.
This is not a complete list of side effects and others may occur. Call your doctor for medical advice about side effects.


Store at 25°C (77°F); excursions permitted between 15°C and 30°C (59°F and 86°F).

Contact us